ARCOSA INC (ACA) Institutional Ownership Changes & 13F Activity

ARCOSA INC (ACA) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include First Eagle U.S. Value, Sequoia Financial Advisors, Renaissance Technologies LLC, Yacktman Asset Management, and ValueAct Holdings.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q3 2019Yacktman Asset ManagementSell-2,941643,194$22,004
Q2 2019ValueAct HoldingsSell-1,500,0004,240,963$159,587
Q2 2019Yacktman Asset ManagementSell-167,612646,135$24,314
Q1 2019ValueAct HoldingsSell-1,395,0005,740,963$175,386
Q1 2019Yacktman Asset ManagementSell-10,768813,747$24,860
Q4 2018ValueAct HoldingsBuy7,135,9637,135,963$197,595
Q4 2018Yacktman Asset ManagementBuy824,515824,515$22,831

Frequently asked questions about ACA activity

  • Which institutional owners are buying ACA?

    Institutional owners buying ACA include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ACA activity?

    "Buy" means an investor increased their reported position in ACA compared to the prior reporting period. This reflects growing exposure to ARCOSA INC (ACA) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ACA increasing?

    Institutional interest in ACA can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related ACA insights